» Articles » PMID: 29742692

Five Common Tumor Biomarkers and CEA for Diagnosing Early Gastric Cancer: A Protocol for a Network Meta-analysis of Diagnostic Test Accuracy

Overview
Specialty General Medicine
Date 2018 May 10
PMID 29742692
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although surgical resection is the recommended treatment for the patients with gastric cancer, lots of patients show advanced or metastatic gastric cancer at the time of diagnosis. Detection of gastric cancer at early stages is a huge challenge because of lack of appropriate detection tests. Unfortunately, existing clinical guidelines focusing on early diagnosis of gastric cancer do not provide consistent and prudent evidence. Serum carcinoembryonic antigen was considered as a complementary test, although it is not good enough to diagnose early gastric cancer. There are no other tumor markers recommended for diagnosing early gastric cancer. This study aims to evaluate and compare the diagnostic accuracy of 5 common tumor biomarkers (CA19-9, CA125, PG, IncRNA, and DNA methylation) and CEA and their combinations for diagnosing gastric cancer through network meta-analysis method, and to rank these tests using a superiority index.

Methods: PubMed, EMBASE.com, and the Cochrane Central Register of Controlled Trials (CENTRAL) will be searched from their inception to March 2018. We will include diagnostic tests which assessed the accuracy of the above-mentioned tumor biomarkers and CEA for diagnosing gastric cancer. The risk of bias for each study will be independently assessed as low, moderate, or high using criteria adapted from Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Network meta-analysis will be performed using STATA 12.0 and R 3.4.1 software. The competing diagnostic tests will be ranked by a superiority index.

Results: This study is ongoing and will be submitted to a peer-reviewed journal for publication.

Conclusion: This study will provide systematically suggestions to select different tumor biomarkers for detecting the early gastric cancer.

Citing Articles

Serum LINC01133 combined with CEA and CA19-9 contributes to the diagnosis and survival prognosis of gastric cancer.

Sui X, Zhang Q, Hao M, Chen Y Medicine (Baltimore). 2024; 103(46):e40564.

PMID: 39560546 PMC: 11575958. DOI: 10.1097/MD.0000000000040564.


Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer.

Mazurek M, Szewc M, Sitarz M, Dudzinska E, Sitarz R Cancers (Basel). 2024; 16(18).

PMID: 39335135 PMC: 11430327. DOI: 10.3390/cancers16183163.


CCL21 and CLDN11 Are Key Driving Factors of Lymph Node Metastasis in Gastric Cancer.

Yang S, Dong D, Bao X, Lu R, Cheng P, Zhu S Cancer Control. 2024; 31:10732748241238616.

PMID: 38553809 PMC: 10981215. DOI: 10.1177/10732748241238616.


Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort study.

Kwak J, Lee Y, Park B, Jung D Front Nutr. 2023; 10:1275450.

PMID: 37904789 PMC: 10613517. DOI: 10.3389/fnut.2023.1275450.


Emergency exploratory laparotomy and radical gastrectomy in patients with gastric cancer combined with acute upper gastrointestinal bleeding.

Kuang F, Wang J, Wang B World J Gastrointest Surg. 2023; 15(7):1423-1433.

PMID: 37555107 PMC: 10405117. DOI: 10.4240/wjgs.v15.i7.1423.


References
1.
Deeks J, Macaskill P, Irwig L . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58(9):882-93. DOI: 10.1016/j.jclinepi.2005.01.016. View

2.
Li L, Catala-Lopez F, Alonso-Arroyo A, Tian J, Aleixandre-Benavent R, Pieper D . The Global Research Collaboration of Network Meta-Analysis: A Social Network Analysis. PLoS One. 2016; 11(9):e0163239. PMC: 5042468. DOI: 10.1371/journal.pone.0163239. View

3.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

4.
Weng W, Dong M, Zhang J, Yang J, Xu Q, Zhu Y . A systematic review of MRI, scintigraphy, FDG-PET and PET/CT for diagnosis of multiple myeloma related bone disease--which is best?. Asian Pac J Cancer Prev. 2014; 15(22):9879-84. DOI: 10.7314/apjcp.2014.15.22.9879. View

5.
Shen M, Wang H, Wei K, Zhang J, You C . Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy. Medicine (Baltimore). 2018; 97(19):e0577. PMC: 5959440. DOI: 10.1097/MD.0000000000010577. View